Medapp

Medapp EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Medapp (MDA.WA) as of Nov 20, 2026 is -4.81 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 6.42 % — a change of -174.85% (lower).

EBIT/Assets

-4.81 %

YoY

-174.85%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Medapp is 2025 -4.81 % . Operating Income to Assets Ratio (EBIT/Assets) of Medapp was 2024 6.42 % . It decreases by -174.85% lower compared to the previous year.

The Medapp EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
-15.14 PLN
Jan 1, 2019
2.92 PLN
Jan 1, 2020
9.11 PLN
Jan 1, 2021
17.21 PLN
Jan 1, 2022
3.53 PLN
Jan 1, 2023
0.92 PLN
Jan 1, 2024
6.42 PLN
Jan 1, 2025
-4.81 PLN
The Medapp EBIT/Assets history
YEAREBIT/AssetsYoY
-4.81 %-174.85%
6.42 %+599.73%
0.92 %-73.96%
3.53 %-79.52%
17.21 %+88.87%
9.11 %+211.61%
2.92 %-119.31%
-15.14 %-32.15%
-22.32 %+68.85%
-13.22 %-175.76%
17.44 %-114.21%
-122.77 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medapp Stock analysis

What does Medapp do? MedApp SA generates revenue through its mobile marketing solutions in the medical field, primarily via the Carna Life software application. Carna Life functions as a telemedicine platform enabling doctors and patients to communicate, with features including data upload and download for test results, offline data review, and graphical statistics. The company serves healthcare providers and patients seeking telemedicine services, focusing on the Polish market through its Krakow headquarters. Moonrock Enterprise SA controls MedApp SA, leveraging its software for medical communication solutions. The firm's revenue model centers on the Carna Life application, which provides telemedicine services by facilitating secure data exchange between doctors and patients. Patients use the app to upload test results, while doctors interpret them through the platform, supported by offline functionality and data visualization tools. This system targets medical professionals and patients in Poland, operating within the telemedicine sector without external partnerships or additional branded products. MedApp SA's business relies solely on the Carna Life telemedicine system, which offers both online and offline modes for data management. The application includes statistics, visualizations, and tables for interpreted medical data, serving as a communication channel between healthcare providers and patients. Controlled by Moonrock Enterprise SA, the company monetizes its software through direct sales to medical institutions and patient users in the Polish healthcare market. Medapp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medapp stock

Operating Income to Assets Ratio (EBIT/Assets) of Medapp is -4.81 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Medapp changed from 6.42 % to -4.81 %, representing a -174.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Medapp since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Medapp with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Medapp

All Key Metrics — Medapp